
Mariella Gruber (Gruber-Olipitz) Filbin MD
Physician
Join to view full profile
450 Brookline AveBoston, MA 02215
Phone+1 617-632-5042
Fax+1 617-582-9969
Dr. Filbin is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2013 - 2016
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2011 - 2013
Karl-Franzens University of Graz Faculty of MedicineClass of 2006
Certifications & Licensure
MA State Medical License 2013 - 2028
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- CD155 regulates tumor growth and susceptibility to T cell mediated killing in diffuse midline glioma.Theophilos Tzaridis, Ester Calvo Fernández, Tanja Eisemann, Angela Liou, Augusto Faria Andrade
Neuro-Oncology. 2026-08-10 - Single-cell multi-omic analyses resolve the cellular diversity of ALK/ROS1/MET/NTRK-fused gliomas in infants and older children.Andrea J De Micheli, Carlos O A de Biagi-Junior, Costanza Lo Cascio, Charbel Machaalani, Andreas Postlmayr
Biorxiv. 2026-07-16 - Forebrain Lineage Factor DMRTA2 Is Not Required for Maintenance of H3G34-Mutant Paediatric High-Grade Gliomas.Raul B Bressan, Oliva Sanchez, Carlos Alberto Oliveira de Biagi-Junior, Raúl Torres-Ruiz, Gustavo Alencastro Veiga Cruzeiro
Journal of Cellular and Molecular Medicine. 2026-07-01
Press Mentions
Dr. Mariella Filbin Receives 2026 Emerging Leader Award From the Mark FoundationJanuary 14th, 2026
FDA-Approved FGFR Inhibitors Show Promise Against Rare and Aggressive Pediatric Brain TumorMay 27th, 2025
Paediatric High-Grade Gliomas: Research Reveals Effective Targeting with AvapritinibApril 1st, 2025
Grant Support
- Mechanism and functional consequences of dietary lipids in lineage specification and tumor growth in oncohistone gliomasDANA-FARBER CANCER INST2024–2029
- How the 3D Architecture of the Brain Shapes Cancer Cell Fate DecisionsDANA-FARBER CANCER INST2021–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:








